Single-Cell Genome Sequencing Market Global Demand, Growth Drivers Analysis & Forecasts Research Report
The global Single-Cell Genome Sequencing Market research report provides complete insights on industry scope, trends, regional estimates, key application, competitive landscape and financial performance of prominent players. It also offers ready data-driven answers to several industry-level questions. This study enables numerous opportunities for the market players to invest in research and development.
Market Overview:
The global single-cell genome sequencing market size is expected to reach USD 2.49 billion by 2025. Single-cell genome sequencing implies analyzing the sequence data with enhanced next-generation sequencing proficiency from a cell. It is a potent instrument that aims to offer intelligence and understanding of genetics by carrying the examination of genomes to the cellular stage.
Key Players:
- Fludigim
- QIAGEN
- Illumina
- F Hoffmann-La Roche Ltd.
- ThermoFisher Scientific, Inc.
- Bio-Rad
- 10X Genomics, Inc.
- BD
- Oxford Nanopore Technologies
- BGI
Request free sample to get a complete analysis of top-performing companies @ https://www.millioninsights.com/industry-reports/single-cell-genome-sequencing-market/request-sample
Growth Drivers:
Factors such as high cost, and analytical challenges in measurement of the single molecule of DNA may hinder the development of the market in the years to come. The Single-cell genome sequencing market is anticipated to grow at a significant CAGR of 14.6% in the upcoming period as the scope, product types and its applications are increasing across the globe.
Technology Outlook:
- NGS
- PCR
- qPCR
- Microarray
- MDA
Disease Area Outlook:
- Cancer
- Immunology
- Prenatal diagnosis
- Neurobiology
- Microbiology
Application Outlook:
- Circulating cells
- Cell differentiation/reprogramming
- Genomic variation
- Subpopulation characterization
Workflow Outlook:
- Single-cell isolation
- Sample preparation
- Genomic analysis
Regional Outlook:
The market may be explored by end users as Biotechnology & biopharmaceutical companies, Clinics, Academic & Research Laboratories, and Others. North America accounted for the major share of the global Single-cell genome sequencing Market Size Analysis in 2016 and will continue to rule the roost in the forecast period.
Browse Related Category Research Reports @ https://blog.naver.com/tomclark
Comments
Post a Comment